Biolife Solutions (BLFS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 27,500 | 20,672 | 28,067 | 25,421 | 22,054 |
| Cost of Goods | 10,004 | 7,708 | 10,146 | 8,988 | 7,254 |
| Gross Profit | 17,496 | 12,964 | 17,921 | 16,433 | 14,800 |
| Operating Expenses | 17,473 | 13,043 | 18,156 | 34,064 | 15,553 |
| Operating Income | 27 | 629 | -89 | -16,643 | -499 |
| Other Income | 1,221 | 2,014 | 792 | 931 | 784 |
| Pre-tax Income | 1,248 | 2,643 | 703 | -15,712 | 285 |
| Income Tax | 62 | -173 | 82 | 126 | 14 |
| Net Income Continuous | 1,186 | 2,816 | 621 | -15,838 | 271 |
| Net Income Discontinuous | N/A | 8,254 | N/A | N/A | -719 |
| Net Income | $1,186 | $11,070 | $621 | $-15,838 | $-448 |
| EPS Basic Total Ops | 0.02 | 0.24 | 0.01 | -0.33 | -0.01 |
| EPS Basic Continuous Ops | 0.02 | 0.06 | 0.01 | -0.33 | 0.01 |
| EPS Basic Discontinuous Ops | N/A | 0.18 | N/A | N/A | -0.02 |
| EPS Diluted Total Ops | 0.02 | 0.23 | 0.01 | -0.33 | -0.01 |
| EPS Diluted Continuous Ops | 0.02 | 0.06 | 0.01 | -0.33 | 0.01 |
| EPS Diluted Discontinuous Ops | N/A | 0.17 | N/A | N/A | -0.02 |
| EPS Diluted Before Non-Recurring Items | 0.04 | 0.04 | 0.04 | 0.00 | 0.04 |
| EBITDA(a) | $726 | $1,215 | $1,246 | $-15,261 | $885 |